Clinical Trial Update: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer [Phase 3]

View source ↗

Summary

A single-arm Phase 3 trial of IMGN853 in Chinese adults with platinum-resistant epithelial ovarian cancer is ongoing, with conditions including epithelial ovari…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• IMGN853

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Epithelial Ovarian Cancer, Peritoneal Cancer | Phase 3 | Status: UNKNOWN